These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3319572)

  • 21. The holy grail in genetic toxicology: follow-up approaches for positive results in the Ames assay.
    Aardema MJ
    Environ Mol Mutagen; 2013 Oct; 54(8):617-20. PubMed ID: 24108513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging approaches in predictive toxicology.
    Zhang L; McHale CM; Greene N; Snyder RD; Rich IN; Aardema MJ; Roy S; Pfuhler S; Venkatactahalam S
    Environ Mol Mutagen; 2014 Dec; 55(9):679-88. PubMed ID: 25044351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Framework for gender differences in human and animal toxicology.
    Gochfeld M
    Environ Res; 2007 May; 104(1):4-21. PubMed ID: 16616135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural analysis in preclinical safety evaluation.
    Fagerland JA; Wall HG; Pandher K; LeRoy BE; Gagne GD
    Toxicol Pathol; 2012; 40(2):391-402. PubMed ID: 22215513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodological innovations expand the safety pharmacology horizon.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
    Rubio Terrés C; Duque I; Tristán C; Galende I
    Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
    Claude JR; Claude N
    Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of molecular, cellular, and genetic neurotoxicology.
    Wallace DR
    Neurol Clin; 2005 May; 23(2):307-20. PubMed ID: 15757786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use and application of stem cells in toxicology.
    Davila JC; Cezar GG; Thiede M; Strom S; Miki T; Trosko J
    Toxicol Sci; 2004 Jun; 79(2):214-23. PubMed ID: 15014205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Data-intensive drug development in the information age: applications of Systems Biology/Pharmacology/Toxicology.
    Kiyosawa N; Manabe S
    J Toxicol Sci; 2016; 41(Special):SP15-SP25. PubMed ID: 28003636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations.
    Son YW; Choi HN; Che JH; Kang BC; Yun JW
    Regul Toxicol Pharmacol; 2020 Oct; 116():104757. PubMed ID: 32758521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tiered approach to pharmacokinetic studies.
    Wilson AG; Frantz SW; Keifer LC
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):5-11. PubMed ID: 7737041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invited contribution: acute toxicity testing, public responsibility and scientific challenges.
    Zbinden G
    Cell Biol Toxicol; 1986 Sep; 2(3):325-35. PubMed ID: 3077080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of global regulatory toxicology requirements for vaccines and adjuvants.
    Sun Y; Gruber M; Matsumoto M
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):49-57. PubMed ID: 22326278
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.